• Exchange: Shenzhen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Hybio Pharmaceutical Co Ltd

+ Add to Watchlist

300199:CH

Trading has been halted for 300199:CH

Snapshot for Hybio Pharmaceutical Co Ltd (300199)

Open: - Day's Range: - Volume: 0
Previous Close: 26.630 52wk Range: 9.810 - 26.740 1-Yr Rtn: -

Stock Chart for 300199

No chart data available.
  • 300199:CH 26.630
  • 1M
  • 1Y
26.630
Interactive 300199 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 300199

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 66.2438
Relative P/E vs. SZ399006 -
Earnings Per Share (CNY) (ttm) 0.3249
Est. EPS (CNY) (12/2014) 0.4020
Est. PEG Ratio -
Market Cap (M CNY) 0.00
Shares Outstanding (M) 400.00
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 0.19%
Cash Dividend (CNY) 0.0500
Dividend Ex-Date 04/26/2013
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 300199

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 300199

Hybio Pharmaceutical Company Limited develops, produces and sells diverse peptide products. The Company's main products are desmopressin acetate injection fluids, thymopentin for injections, somatostatin for injections and terlipressin for injections.

Zeng ShaoguiChairmanYuan JianchengPresident
Ma YapingVP:R & DYu PinxiangVP:Production
More Company Profile & Key Executives for 300199

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil